Keytruda
oncology biologic
1 conceptPembrolizumab immunotherapy used across many early-stage and metastatic cancer indications.
ProductsMerck & Co.
Merck & Co. product analyses
A tighter look at the products that matter most to Merck & Co., along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.
Products
Where the moat actually touches users
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 2 structured disruption concepts across the current product set.
2 disruption concepts tracked0 documented exceptions
Gardasil 9
hpv vaccine
1 conceptHuman papillomavirus vaccine franchise used to prevent HPV-linked cancers, precancerous lesions, and genital warts.
Paper trail
Company-level source stack
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
Merck Announces Fourth-Quarter and Full-Year 2025 Financial Results
Merck & Co., Inc. · investor relations
Primary source for company revenue, net income, and the FY2025 sales weight of KEYTRUDA, GARDASIL, and Animal Health.
Reviewed 2026-03-25
Merck Quarterly Report on Form 10-Q for the quarter ended September 30, 2025
Merck & Co., Inc. · regulatory filing
Supports KEYTRUDA royalty disclosures and product concentration context from a regulatory filing.
Reviewed 2026-03-25
Merck & Co. Market Cap
Stock Analysis · market data
Time-bound market-cap snapshot used for the company market-cap metric.
Reviewed 2026-03-25
Merck & Co (MRK) PE Ratio
FinanceCharts · market data
Time-bound trailing P/E snapshot used for the valuation metric.
Reviewed 2026-03-25